Vor Biopharma Inc.
VOR
$0.572
$0.02835.21%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.44% | 1.01% | 9.63% | -17.30% | 20.88% |
| Total Depreciation and Amortization | 1.65% | -2.07% | -7.85% | 5.72% | -0.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.73% | -5.20% | 5.66% | 65.69% | -32.23% |
| Change in Net Operating Assets | 2,944.44% | -107.03% | 134.17% | -428.88% | -161.44% |
| Cash from Operations | -3.34% | -6.58% | 28.29% | -26.80% | 13.88% |
| Capital Expenditure | -111.76% | -277.78% | 92.11% | -2.70% | 76.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 20.21% | 322.05% | -74.52% |
| Cash from Investing | -111.76% | -100.06% | 20.51% | 325.48% | -74.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50,027.03% | 455.00% | -92.81% | 491.49% | -88.13% |
| Repurchase of Common Stock | 57.14% | -37.25% | 71.98% | -727.27% | 90.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 129,865.85% | 232.26% | -132.29% | 284.00% | -85.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 225.23% | -174.82% | 128.70% | 199.55% | -206.65% |
